Loading...
| A03598 | Pages: NA | Dec 2021 | 4836 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Calming And Sleeping Market
Request Now !Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system. They are used to treat insomnia, sleep apnea, and other sleep disorders.
The rise in hectic, stressful life, and reduced sleep time due to modern lifestyles such as digital communication, games, work, and social responsibilities drive the growth of the calming and sleeping market. The increasing trend of late night coffee and tea consumption leads to a disturbance in sleeping patterns that fuel the growth of the calming and sleep market. In addition, the rising prevalence of sleep disorders such as insomnia, sleep apnea, sleep walking, and bruxism among others is anticipated to propel the market growth.
However, dependence, adverse effects, misuse of calming and sleeping products, & stringent government regulations related to the safety and efficacy of calming & sleeping products hinder the market growth. Ongoing R&D activities related to calming and sleeping products are anticipated to present new opportunities for the market.
The market is segmented on the basis of product type, application, and geography. Based on product type, the market is categorized into medication, sleep laboratories, sleep apnea devices, and mattresses & pillows. By application, it is segmented into insomnia, sleep apnea, restless leg syndrome (RLS), bruxism, narcolepsy, and sleepwalking. The geographical breakdown of each of the aforesaid segments has been covered for North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
List of players profiled in the report
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 CALMING AND SLEEPING MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. MEDICATIONS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Prescriptions
4.2.4.1. Market size and forecast
4.2.5. Over-The-Counter (OTC)
4.2.5.1. Market size and forecast
4.3. SLEEP LABORATORIES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. SLEEP APNEA DEVICES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. MATTRESSES AND PILLOWS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 CALMING AND SLEEPING MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. INSOMNIA
5.2.1. Market size and forecast
5.3. SLEEP APNEA
5.3.1. Market size and forecast
5.4. RESTLESS LEG SYNDROME (RLS)
5.4.1. Market size and forecast
5.5. BRUXISM
5.5.1. Market size and forecast
5.6. NARCOLEPSY
5.6.1. Market size and forecast
5.7. SLEEPWALKING
5.7.1. Market size and forecast
CHAPTER 6 CALMING AND SLEEPING MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Calming and Sleeping Market by Product Type
6.2.5. North America Calming and Sleeping Market by Application
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Calming and Sleeping Market by Product Type
6.3.5. Europe Calming and Sleeping Market by Application
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Calming and Sleeping Market by Product Type
6.4.5. Asia-Pacific Calming and Sleeping Market by Application
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Latin America market size and forecast
6.5.3.2. Middle East market size and forecast
6.5.3.3. Africa market size and forecast
6.5.4. LAMEA Calming and Sleeping Market by Product Type
6.5.5. LAMEA Calming and Sleeping Market by Application
CHAPTER 7 COMPANY PROFILES
7.1. ELI LILLY AND COMPANY
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. ASTRAZENECA PLC.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. JOHNSON & JOHNSON
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. SUNOVION PHARMACEUTICALS, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ROSCOE MEDICAL INC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. ACURA PHARMACEUTICALS, INC.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. CARA THERAPEUTICS
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. COLLEGIUM PHARMACEUTICAL, INC
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. DURECT CORPORATION
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
